Mihriban Tuna has a diverse background in the biopharmaceutical industry, with experience in drug discovery and technology development. Currently serving as an Entrepreneur In Residence at Cambridge Innovation Capital, Mihriban previously held positions such as CSO at Takeda and Chief Scientific Officer at Adaptate. With a solid foundation in biochemistry and biology from their education at University of Sussex and Orta Doğu Teknik Üniversitesi, Mihriban has contributed significantly to the field through roles at F-star Therapeutics, GSK, and Domantis.
October, 2022 - present
Entrepreneur in Residence at tokenstreet
Entrepreneur in Residence at Copley Equity Partners
Entrepreneur in Residence at Kentucky Innovation Network
Entrepreneur In Residence at Celtic House Asia Partners
Entrepreneur In Residence at TandemLaunch